Emerging Technologies in Biomanufacturing

This series delivers authoritative resources at the intersection of biopharmaceutical science, engineering, and manufacturing. This collaboration leverages BPI's industry expertise and CRC Press's scholarly publishing excellence to provide comprehensive references for professionals advancing biotherapeutic and biodiagnostic development. The series encompasses the complete biopharmaceutical development and manufacturing continuum, including upstream processing (cell line development, fermentation strategies, bioreactor design), downstream processing (purification approaches, continuous processing, membrane technologies), analytical methods (bioassays, characterization techniques, quality control), manufacturing technologies (single-use systems, automation, facility design), emerging modalities (cell and gene therapies, mRNA platforms), regulatory science (quality by design, validation strategies), and business operations (supply chain optimization, outsourcing strategies).

The series targets bioprocess professionals and engineers, R&D specialists, pharmaceutical manufacturing professionals, quality assurance personnel, academic researchers, contract organizations, and industry consultants. This initiative aims to accelerate innovation in biopharmaceutical development by providing actionable insights that bridge theoretical knowledge with practical implementation, ultimately supporting the efficient delivery of safe, effective, and affordable biotherapeutics to patients worldwide.